☰

NA-RA LEE - Publications

Affiliations: 
University of Kentucky, Lexington, KY 
Area:
Neuropharmacology, Drug Discovery, Behavioral Pharmacology, Cancer Research, Virus Enzyme Kinetics
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lee NR, Zheng G, Leggas M, Janganati V, Nickell JR, Crooks PA, Bardo MT, Dwoskin L. GZ-11608, a Vesicular Monoamine Transporter-2 Inhibitor, Decreases the Neurochemical and Behavioral Effects of Methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. PMID 31413138 DOI: 10.1124/Jpet.119.258699  0.332
2018 Lee NR, Gujarathi S, Bommagani S, Siripurapu K, Zheng G, Dwoskin LP. Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M - M muscarinic acetylcholine receptors. Bioorganic & Medicinal Chemistry Letters. PMID 30554957 DOI: 10.1016/J.Bmcl.2018.12.022  0.305
2018 Lee NR, Zheng G, Crooks PA, Bardo MT, Dwoskin LP. New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. The Aaps Journal. 20: 29. PMID 29427069 DOI: 10.1208/S12248-018-0192-Y  0.348
2014 Kasam V, Lee NR, Kim KB, Zhan CG. Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening. Bioorganic & Medicinal Chemistry Letters. 24: 3614-7. PMID 24913713 DOI: 10.1016/J.Bmcl.2014.05.025  0.346
2014 Miller ZC, Wu Y, Lee N, Zhou S, Kim K. Abstract 1808: Potentiation of proteasome inhibitor cytotoxicity by co-treatment with novel β1i-selective immunoproteasome inhibitors Cancer Research. 74: 1808-1808. DOI: 10.1158/1538-7445.Am2014-1808  0.382
2013 Miller ZC, Lee D, Lee N, Kim K, Lee W, Kim KB. Abstract 1021: The development of non-covalent non-peptide inhibitors of the proteasome: exploring a series of proteasome-inhibiting pyrazoles. Cancer Research. 73: 1021-1021. DOI: 10.1158/1538-7445.Am2013-1021  0.37
2012 Sharma LK, Lee NR, Jang ER, Lei B, Zhan CG, Lee W, Kim KB. Activity-based near-infrared fluorescent probe for LMP7: a chemical proteomics tool for the immunoproteasome in living cells. Chembiochem : a European Journal of Chemical Biology. 13: 1899-903. PMID 22807337 DOI: 10.1002/Cbic.201200307  0.339
2012 Carmony KC, Lee DM, Wu Y, Lee NR, Wehenkel M, Lee J, Lei B, Zhan CG, Kim KB. A bright approach to the immunoproteasome: development of LMP2/β1i-specific imaging probes. Bioorganic & Medicinal Chemistry. 20: 607-13. PMID 21741845 DOI: 10.1016/J.Bmc.2011.06.039  0.353
2012 Lee N, Carmony KC, Wu Y, Miller Z, Kim K. Abstract 4744: Development of an immunoproteasome fluorescent substrate: A functional proteomics tool Cancer Research. 72: 4744-4744. DOI: 10.1158/1538-7445.Am2012-4744  0.363
2012 Sharma LK, Lee N, Jang ER, Lei B, Zhan C, Lee W, Kim K. Cover Picture: Activity-Based Near-Infrared Fluorescent Probe for LMP7: A Chemical Proteomics Tool for the Immunoproteasome in Living Cells (ChemBioChem 13/2012) Chembiochem. 13: 1829-1829. DOI: 10.1002/Cbic.201290053  0.316
2011 Cornish K, Wu Y, Lee D, Lee N, Wehenkel M, Lee J, Kim K. Abstract 2621: Development of Fluoro-UK-101, an immunoproteasome-targeting activity-based fluorescent probe Cancer Research. 71: 2621-2621. DOI: 10.1158/1538-7445.Am2011-2621  0.382
Show low-probability matches.